UNIVERSITY OF WOLLONGONG
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uow.edu.au
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Optimal Implementation of Antimicrobial Stewardship in General Practice
- Conditions
- The Use of Antimicrobial Stewardship in in General Practice (Family Medicine)Respiratory Tract Infections (RTI)
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- University of Wollongong
- Target Recruit Count
- 120
- Registration Number
- NCT06953804
A Nurse-led Intervention on Frailty Status of Ethiopian Older Persons
- Conditions
- Frailty
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- University of Wollongong
- Target Recruit Count
- 68
- Registration Number
- NCT05754398
- Locations
- 🇪🇹
Bahir Dar University, Bahir Dar, Amhara, Ethiopia
Effectiveness of High Protein Diets in Promoting Weight Loss in Overweight and Obese Subjects.
- Conditions
- Overweight
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- University of Wollongong
- Target Recruit Count
- 45
- Registration Number
- NCT00421616
- Locations
- 🇦🇺
Smart Foods Centre, University of Wollongong, Wollongong, New South Wales, Australia
Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity?
- Conditions
- Obesity
- First Posted Date
- 2005-04-07
- Last Posted Date
- 2006-09-13
- Lead Sponsor
- University of Wollongong
- Target Recruit Count
- 216
- Registration Number
- NCT00107692
- Locations
- 🇦🇺
University of Newcastle, Newcastle, New South Wales, Australia
🇦🇺Child Obesity Research Centre, University of Wollongong, Wollongong, New South Wales, Australia
News
Implantable Biobattery Achieves 99.6% Tumor Reduction in Breakthrough Drug-Free Cancer Treatment
A novel implantable biobattery developed by researchers at University of Wollongong and Jilin University reduced tumor size from over 1,000 mm³ to just 4 mm³ in 14 days, achieving a 99.6% reduction.
University of Wollongong Secures $500K Grant to Advance ResectAssist™ Cancer Device for Pancreatic Tumors
University of Wollongong researchers received $500,000 from Australian Economic Accelerate Ignite Grants to develop ResectAssist™, a biodegradable implantable device for inoperable pancreatic cancer.